MediPharm Labs (TSE:LABS) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
MediPharm Labs is selling its Napanee facility to Kensana Health for $5.5 million, forming a strategic partnership to enhance their manufacturing capabilities and support future growth. This move aligns with MediPharm’s strategy to streamline operations and maximize stakeholder value, while Kensana aims to advance its phytopharmaceutical development. The deal is expected to close by January 1, 2025.
For further insights into TSE:LABS stock, check out TipRanks’ Stock Analysis page.